Trade Omnicell Inc - OMCL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.19 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 41.75 |
| Open | 42.21 |
| 1-Year Change | 28.1% |
| Day's Range | 42.21 - 43.97 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | 43.97 | 2.16 | 5.17% | 41.81 | 44.11 | 41.67 |
| Nov 20, 2024 | 41.75 | -0.20 | -0.48% | 41.95 | 42.07 | 41.21 |
| Nov 19, 2024 | 42.36 | -0.23 | -0.54% | 42.59 | 43.58 | 41.95 |
| Nov 18, 2024 | 46.00 | 0.20 | 0.44% | 45.80 | 46.87 | 45.62 |
| Nov 15, 2024 | 45.62 | -0.94 | -2.02% | 46.56 | 46.90 | 45.61 |
| Nov 14, 2024 | 46.53 | -0.95 | -2.00% | 47.48 | 48.34 | 46.39 |
| Nov 13, 2024 | 47.76 | -0.60 | -1.24% | 48.36 | 48.91 | 47.58 |
| Nov 12, 2024 | 48.83 | 0.52 | 1.08% | 48.31 | 49.68 | 48.31 |
| Nov 11, 2024 | 48.82 | -0.95 | -1.91% | 49.77 | 50.06 | 48.17 |
| Nov 8, 2024 | 50.09 | -0.67 | -1.32% | 50.76 | 52.57 | 50.05 |
| Nov 7, 2024 | 52.45 | 0.85 | 1.65% | 51.60 | 53.21 | 51.60 |
| Nov 6, 2024 | 52.43 | 1.29 | 2.52% | 51.14 | 52.84 | 49.98 |
| Nov 5, 2024 | 49.76 | 1.81 | 3.77% | 47.95 | 50.04 | 47.95 |
| Nov 4, 2024 | 48.46 | 0.20 | 0.41% | 48.26 | 49.48 | 47.80 |
| Nov 1, 2024 | 48.61 | 0.27 | 0.56% | 48.34 | 49.44 | 47.76 |
| Oct 31, 2024 | 48.69 | -3.29 | -6.33% | 51.98 | 51.99 | 47.43 |
| Oct 30, 2024 | 52.95 | 8.40 | 18.86% | 44.55 | 55.60 | 44.55 |
| Oct 29, 2024 | 40.07 | 0.53 | 1.34% | 39.54 | 40.32 | 39.54 |
| Oct 28, 2024 | 40.32 | 0.87 | 2.21% | 39.45 | 41.18 | 39.45 |
| Oct 25, 2024 | 39.42 | 0.36 | 0.92% | 39.06 | 39.78 | 39.06 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Omnicell Company profile
About Omnicell, Inc.
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. Its point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility’s in-house information management systems. Its Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Omnicell, Inc. revenues increased 27% to $1.13B. Net income increased from $32.2M to $77.8M. Revenues reflect Connected devices, software licenses, and other segment increase of 32% to $739.1M, SaaS, subscription software, and technology-enabled services segment increase from $53.8M to $112.5M, United States segment increase of 28% to $1.02B, Rest of the World segment increase of 18% to $111.2M.
Equity composition
Common Stock $.001 Par, 12/10, 100M auth., 37,148,706 issd. 4,121,123 shs. in Treas. @$65.1M. Insiders own 2.25%. Initial Public Offering: 8/07/01, 6Mshares @ $7 by U.S. Bancorp Piper Jaffray. 7/01 1-for-1.6 stock split. *NOTE: 8/01, the Company changed it's name from Omnicell.com.
| Industry: | Medical Software & Technology Services |
4220 North Freeway
FORT WORTH
TEXAS 76137
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com